Delano Ladd Sells 1,500 Shares of HealthEquity (NASDAQ:HQY) Stock

HealthEquity, Inc. (NASDAQ:HQY) EVP Delano Ladd sold 1,500 shares of the firm’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $94.72, for a total transaction of $142,080.00. Following the completion of the transaction, the executive vice president directly owned 73,979 shares in the company, valued at $7,007,290.88. This represents a 1.99% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Delano Ladd also recently made the following trade(s):

• On Thursday, November 20th, Delano Ladd sold 1,500 shares of HealthEquity stock. The shares were sold at an average price of $104.56, for a total value of $156,840.00.
• On Monday, October 20th, Delano Ladd sold 1,500 shares of HealthEquity stock. The stock was sold at an average price of $92.07, for a total value of $138,105.00.

HealthEquity Trading Down 0.2%

NASDAQ:HQY opened at $92.47 on Thursday. The firm has a market capitalization of $7.90 billion, a P/E ratio of 42.42, a P/E/G ratio of 1.34 and a beta of 0.18. The business has a 50 day simple moving average of $97.21 and a 200 day simple moving average of $96.03. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.13 and a quick ratio of 4.13. HealthEquity, Inc. has a 12-month low of $74.07 and a 12-month high of $116.65.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The firm had revenue of $322.16 million for the quarter, compared to analyst estimates of $320.92 million. During the same period last year, the company earned $0.78 earnings per share. The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Equities research analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current year.

Institutional Trading of HealthEquity

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Farther Finance Advisors LLC boosted its stake in HealthEquity by 232.4% during the second quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock valued at $26,000 after buying an additional 172 shares in the last quarter. WPG Advisers LLC acquired a new stake in HealthEquity in the 1st quarter valued at about $28,000. True Wealth Design LLC boosted its position in shares of HealthEquity by 3,522.2% during the 3rd quarter. True Wealth Design LLC now owns 326 shares of the company’s stock valued at $31,000 after purchasing an additional 317 shares in the last quarter. Caitong International Asset Management Co. Ltd acquired a new position in shares of HealthEquity in the 2nd quarter worth approximately $33,000. Finally, Cullen Frost Bankers Inc. grew its stake in shares of HealthEquity by 172.3% in the 2nd quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock worth $37,000 after purchasing an additional 224 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Barclays started coverage on shares of HealthEquity in a research note on Monday, December 8th. They issued an “overweight” rating and a $118.00 price target on the stock. BMO Capital Markets restated a “market perform” rating on shares of HealthEquity in a research report on Thursday, December 4th. JPMorgan Chase & Co. boosted their price target on HealthEquity from $126.00 to $129.00 and gave the stock an “overweight” rating in a research report on Thursday, December 4th. Citizens Jmp increased their price target on HealthEquity from $117.00 to $122.00 and gave the stock a “market outperform” rating in a research note on Thursday, December 4th. Finally, Barrington Research reissued an “outperform” rating and set a $125.00 price target on shares of HealthEquity in a report on Thursday, December 4th. Two equities research analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $120.27.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.